MedTrace Logo

Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

NCT05469503 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 410

Last updated 2024-04-23

No results posted yet for this study

Summary

This clinical study aims to assess the efficacy of TOTUM-854, a mix of 6 plant extracts, consumed twice a day on automated office blood pressure in subjects with moderately elevated blood pressure. The hypothesis is that TOTUM-854 is superior to placebo for decrease of automated office blood pressure after 12 weeks of consumption.

Conditions

  • Prehypertension
  • Elevated Blood Pressure
  • Blood Pressure
  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

TOTUM-854

12 weeks of TOTUM-854 supplementation

DIETARY_SUPPLEMENT

Placebo

12 weeks of placebo supplementation

Sponsors & Collaborators

  • Excelya

    collaborator INDUSTRY

  • Valbiotis

    lead INDUSTRY

Principal Investigators

  • Katarzyna Pałka, Dr · Centrum Medyczne Linden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2024-09-01
Completion
2024-12-01

Countries

  • Bulgaria
  • France
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05469503 on ClinicalTrials.gov